Objective: Anti-synthetase syndrome (ASSD) is a rare systemic autoimmune rheumatic disease (SARD) with significant heterogeneity and no shared classification criteria. We aimed to identify clinical and serological features associated with ASSD that may be suitable for inclusion in the data-driven classification criteria for ASSD. Methods: We used a large, international, multicenter “Classification Criteria for Anti-synthetase Syndrome” (CLASS) project database, which includes both patients with ASSD and controls with mimicking conditions, namely, SARDs and/or interstitial lung disease (ILD). The local diagnoses of ASSD and controls were confirmed by project team members. We employed univariable logistic regression and multivariable Ridge regression to evaluate clinical and serological features associated with an ASSD diagnosis in a randomly selected subset of the cohort. Results: Our analysis included 948 patients with ASSD and 1,077 controls. Joint, muscle, lung, skin, and cardiac involvement were more prevalent in patients with ASSD than in controls. Specific variables associated with ASSD included arthritis, diffuse myalgia, muscle weakness, muscle enzyme elevation, ILD, mechanic's hands, secondary pulmonary hypertension due to ILD, Raynaud phenomenon, and unexplained fever. In terms of serological variables, Jo-1 and non–Jo-1 anti-synthetase autoantibodies, antinuclear antibodies with cytoplasmic pattern, and anti-Ro52 autoantibodies were associated with ASSD. In contrast, isolated arthralgia, dysphagia, electromyography/magnetic resonance imaging/muscle biopsy findings suggestive of myopathy, inflammatory rashes, myocarditis, and pulmonary arterial hypertension did not differentiate between patients with ASSD and controls or were inversely associated with ASSD. Conclusion: We identified key clinical and serological variables associated with ASSD, which will help clinicians and offer insights into the development of data-driven classification criteria for ASSD. (Figure presented.).
Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project / Faghihi‐kashani, Sara; Yoshida, Akira; Bozan, Francisca; Zanframundo, Giovanni; Rozza, Davide; Loganathan, Aravinthan; Dourado, Eduardo; Sambataro, Gianluca; Bauer‐ventura, Iazsmin; Bae, Sangmee Sharon; Lim, Darosa; Rivero‐gallegos, Daphne; Yamano, Yasuhiko; Selva‐o'Callaghan, Albert; Mammen, Andrew L.; Scirè, Carlo A.; Montecucco, Carlomaurizio; Oddis, Chester V.; Fiorentino, David; Bonella, Francesco; Miller, Frederick W.; Lundberg, Ingrid E.; Schmidt, Jens; Rojas‐serrano, Jorge; Hudson, Marie; Kuwana, Masataka; González‐gay, Miguel Angel; Mchugh, Neil; Corte, Tamera J.; Doyle, Tracy Jennifer; Werth, Victoria P.; Gupta, Latika; Perez Roman, Diana Isabel; Bianchessi, Lorenzo M.; Devarasetti, Phani Kumar; Shinjo, Samuel Katsuyuki; Luppi, Fabrizio; Cavazzana, Ilaria; Moghadam‐kia, Siamak; Fornaro, Marco; Volkmann, Elizabeth R.; Piga, Matteo; Loarce‐martos, Jesus; De Luca, Giacomo; Knitza, Johannes; Wolff‐cecchi, Veronica; Sebastiani, Marco; Schiffenbauer, Adam; Rider, Lisa G.; Campanilho‐marques, Raquel; Marts, Lucian; Bravi, Elena; Gunawardena, Harsha; Aggarwal, Rohit; Cavagna, Lorenzo; Null, Null. - In: ARTHRITIS & RHEUMATOLOGY. - ISSN 2326-5191. - 77:4(2025), pp. 477-489. [10.1002/art.43038]
Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project
Luppi, Fabrizio;Sebastiani, Marco;
2025
Abstract
Objective: Anti-synthetase syndrome (ASSD) is a rare systemic autoimmune rheumatic disease (SARD) with significant heterogeneity and no shared classification criteria. We aimed to identify clinical and serological features associated with ASSD that may be suitable for inclusion in the data-driven classification criteria for ASSD. Methods: We used a large, international, multicenter “Classification Criteria for Anti-synthetase Syndrome” (CLASS) project database, which includes both patients with ASSD and controls with mimicking conditions, namely, SARDs and/or interstitial lung disease (ILD). The local diagnoses of ASSD and controls were confirmed by project team members. We employed univariable logistic regression and multivariable Ridge regression to evaluate clinical and serological features associated with an ASSD diagnosis in a randomly selected subset of the cohort. Results: Our analysis included 948 patients with ASSD and 1,077 controls. Joint, muscle, lung, skin, and cardiac involvement were more prevalent in patients with ASSD than in controls. Specific variables associated with ASSD included arthritis, diffuse myalgia, muscle weakness, muscle enzyme elevation, ILD, mechanic's hands, secondary pulmonary hypertension due to ILD, Raynaud phenomenon, and unexplained fever. In terms of serological variables, Jo-1 and non–Jo-1 anti-synthetase autoantibodies, antinuclear antibodies with cytoplasmic pattern, and anti-Ro52 autoantibodies were associated with ASSD. In contrast, isolated arthralgia, dysphagia, electromyography/magnetic resonance imaging/muscle biopsy findings suggestive of myopathy, inflammatory rashes, myocarditis, and pulmonary arterial hypertension did not differentiate between patients with ASSD and controls or were inversely associated with ASSD. Conclusion: We identified key clinical and serological variables associated with ASSD, which will help clinicians and offer insights into the development of data-driven classification criteria for ASSD. (Figure presented.).| File | Dimensione | Formato | |
|---|---|---|---|
|
Arthritis Rheumatology - 2024 - Faghihi‐Kashani - Clinical Characteristics of Anti‐Synthetase Syndrome Analysis From the.pdf
Open access
Tipologia:
VOR - Versione pubblicata dall'editore
Licenza:
[IR] creative-commons
Dimensione
2.49 MB
Formato
Adobe PDF
|
2.49 MB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate

I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris




